← Scroll for more →
Resmed Inc (RMD)
Surgical & Medical Instruments & Apparatus
Latest Price
$252.83
TTM P/E
24.38
Normalized P/E
33.25
TTM Div Yield
0.95%
Fwd Div Yield
0.95%
Book Value
44.56
P/B Ratio
5.67
Valuation metrics
adjust assumptions →EPS: $10.43
Book value / share: $45.66
Formula: √(22.5 × EPS × BVPS)
Graham Number
$103.51
59% downside
Norm. op. income: $1.1B (median of 7yr)
Tax rate: 19%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$69.29
73% downside
Base FCF: $1.3B (median of recent 5yr)
Growth: 12%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$267.00
+6% upside
EPS: $10.43
Target P/E: 33×
Formula: EPS × P/E
P/E Fair Value
$344.19
+36% upside
Institutional Ownership
69.1% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 12.32M | $2.40B | 8.54% | +223.2K | 2026-06-30 |
| Vanguard Capital Management LLC | 9.47M | $1.85B | 6.57% | +7.7K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 7.91M | $1.54B | 5.49% | +49.7K | 2026-06-30 |
| State Street Corp | 6.68M | $1.30B | 4.63% | +37.6K | 2026-06-30 |
| Geode Capital Management, LLC | 4.35M | $845.0M | 3.02% | -553 | 2026-06-30 |
| Bank of New York Mellon Corp | 4.20M | $818.0M | 2.91% | -727.8K | 2026-06-30 |
| First Trust Advisors LP | 2.28M | $444.0M | 1.58% | +740.9K | 2026-06-30 |
| Invesco Ltd. | 2.06M | $402.0M | 1.43% | +107.0K | 2026-06-30 |
| Morgan Stanley | 1.93M | $375.0M | 1.34% | -757.9K | 2026-06-30 |
| Northern Trust Corp | 1.70M | $330.0M | 1.18% | -29.0K | 2026-06-30 |